Table 2 Epigenome-wide significant (FDR < 0.05) CpGs identified in EWAS meta-analyses for lifetime cannabis use from Model 2, adjusted for cigarette smoking.

From: Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use

CpG

Chr:Position (hg19)

Closest genes

Locationa

Model 2 in all participants (N = 9436)

Model 1 in all participants (N = 9436)

Model 1 in participants who never smoked cigarettes (N = 4146)

EWAS meta-analysis of cigarette smoking [48] (current vs. non-current)

Direction

Effectb

P-value

Effectb

P-value

Effectb

P-value

Effectc

Direction

P-value

cg01101459

1:234871477

LINC01132

TFBS

−+−−−+−−−−

−0.0042

3.90E-07

−0.0030

2.27E-04

−0.0034

0.0064

0.18

+++−+

0.014

cg22572071

6:47074382

ADGRF1

Enhancer

++++++++++

0.0040

1.09E-07

0.0028

9.51E-05

0.0024

0.025

0.0074

+−+−+

0.91

cg15280358

10:127904472

ADAM12

Gene body

+−++?++++−

0.0058

5.15E-07

0.0044

8.32E-05

0.0040

0.016

−0.11

+−−−+

0.22

cg00813162

14:69443362

ACTN1

5′UTR

−+−−−−−−−−

−0.0028

2.46E-07

−0.0024

5.51E-06

−0.0025

0.0019

0.023

++−?+

0.69

cg14237301

16:28506477

APOBR

1st Exon; 5′ UTR

−−−−−−−?−

−0.0040

1.76e-05

−0.0032

3.10E-4

−0.0071

9.05E-08

0.070

−++++

0.37

  1. aTFBS: Transcription Factor Binding Site; 5′UTR: 5′ untranslated region.
  2. bPositive effect size means higher methylation (hypermethylation) in ever cannabis users.
  3. cPositive effect size means higher methylation (hypermethylation) in current cigarette smokers.